US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

KraneShares MSCI All China Health Care Index ETF

19.11

-0.2300-1.19%

Pre-market: 18.50-0.6100-3.19%07:56 EDT

Volume:41.37K

Turnover:790.49K

Market Cap:110.86M

PE:- -

High:19.18

Open:19.18

Low:19.05

Close:19.34

52wk High:21.88

52wk Low:14.38

Shares:5.80M

Float Shares:5.80M

Volume Ratio:0.60

T/O Rate:0.71%

Dividend:0.71

Dividend Rate:3.74%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Moderna's Personalized mRNA Vaccine Achieves First Success, Chinese Innovators Line Up

China's Simcere Pharmaceutical H1 Revenue Rises on Neuroscience, Autoimmune Drugs Strength

Pharma Sector Doubles Down on AI Amid Hopes of Slashing Costs, Timelines

Southbound Capital Daily: Net Selloff Hits HK$10.41B, Alibaba Draws Mainland Buying Pre-Earnings, Healthcare Stocks Split

Hong Kong Stocks Rise on Thursday on Easing Bond Concerns, Tech Gains; CSPC Pharma Jumps 9%

MT Newswires Live

CSPC Pharma Surges 15% as Moderna's mRNA Cancer Vaccine Hits Key Milestone

Norway's Vistin Pharma Q2 Revenue Falls on Currency Impact

CSPC Pharma (01093) Surges Over 12% After Interim Profit Jumps Nearly 1.4-Fold

CSPC Pharmaceutical Hits 6-Month High on Profit, Dividend Surge

CSPC Pharmaceutical's Attributable Profit More Than Doubles in H1; Shares Jump 14%

MT Newswires Live

CSPC Pharma FY26 H1 Profit Attributable to Shareholders More than Doubled to RMB 6.09 Billion; Revenue Rises 40.1% to RMB 18.59 Billion

CSPC Pharmaceutical Group H1 Net Income Attributable RMB 6,094.2 Million

THOMSON REUTERS

CSPC Pharmaceutical Group - Interim Dividend of HK18 Cents Per Share for 2026

THOMSON REUTERS

Biotech Sector Surges as Moderna's Melanoma Vaccine Milestone Sparks Oncology and mRNA Repricing

Akeso (SEHK:9926) Could Be 47% Undervalued As China Approves Ivonescimab Use

Simply Wall St.

CSPC Pharmaceutical Group Stock Sheds 1.3% in Hong Kong, Underperforms Competitors

Wuxi Biologics (Cayman) Stock Falls 1.4% in Hong Kong

Does FDA-Backed Mpox mRNA Trial and AstraZeneca Tie-Up Recast the Bull Case For CSPC (SEHK:1093)?

Simply Wall St.

Innovent Biologics (SEHK:1801), Why Is It Back In The Spotlight?

Simply Wall St.

CSPC Pharma Says NMPA Accepts NDA for KN026 and Hb1801 for Advanced Breast Cancer

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.gotigerhk.com/stock/KURE/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"KURE","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"KURE\",,,,,undefined,":{"symbol":"KURE","market":"US","secType":"STK","nameCN":"KraneShares MSCI All China Health Care Index ETF","latestPrice":19.11,"timestamp":1787342400000,"preClose":19.34,"halted":0,"volume":41373,"hourTrading":{"tag":"盘前","latestPrice":18.5,"preClose":19.11,"latestTime":"07:56 EDT","volume":54,"amount":998.020008,"timestamp":1787572607542,"change":-0.61,"changeRate":-0.03192,"amplitude":0.005128},"delay":0,"changeRate":-0.011892450879007262,"floatShares":5800979,"shares":5800979,"eps":0,"marketStatus":"Pre-Mkt","change":-0.23,"latestTime":"08-24 09:12:41 EDT","open":19.18,"high":19.18,"low":19.05,"amount":790485.7773600001,"amplitude":0.006722,"askPrice":20.99,"askSize":100,"bidPrice":16.83,"bidSize":100,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1787578200000},"marketStatusCode":1,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":19.11,"sharesOutstanding":4750002,"nav":18.99,"aum":110160584.96,"dividendRate":0.037405,"bidAskSpread":0.003071,"preHourTrading":{"tag":"盘前","latestPrice":18.5,"preClose":19.11,"latestTime":"07:56 EDT","volume":54,"amount":998.020008,"timestamp":1787572607542,"change":-0.61,"changeRate":-0.03192,"amplitude":0.005128},"postHourTrading":{"tag":"盘后","latestPrice":19.33,"preClose":19.11,"latestTime":"19:13 EDT","volume":111,"amount":2143.44,"timestamp":1787353996933,"change":0.22,"changeRate":0.011512,"amplitude":0.011512},"volumeRatio":0.6042676883302781,"impliedVol":0.3186,"impliedVolPercentile":0.66},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"KURE\",,,,,undefined,":{"symbol":"KURE","floatShares":5800979,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.6042676883302781,"shares":5800979,"dividePrice":0.7148,"high":19.18,"amplitude":0.006722,"preClose":19.34,"low":19.05,"week52Low":14.3797,"pbRate":"--","week52High":21.875,"institutionHeld":0,"latestPrice":19.11,"eps":0,"divideRate":0.037405,"volume":41373,"delay":0,"ttmEps":0,"open":19.18,"prevYearClose":17.04,"prevWeekClose":19.11,"prevMonthClose":17.28,"prevQuarterClose":15.747,"fiveDayClose":18.43,"twentyDayClose":17.2112,"sixtyDayClose":16.09},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/KURE\",params:#limit:5,,,undefined,":[{"date":"2025-12-22","symbol":"KURE","amount":0.714689,"announcedDate":"2025-12-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-22","defaultRemindTime":1766413800000,"name":"KraneShares MSCI All China Health Care Index ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-23","payableDate":"2025-12-22","currency":"USD","dateTimestamp":1766379600000,"payDate":"2025-12-23"},{"date":"2024-12-17","symbol":"KURE","amount":0.18361,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-12-17","defaultRemindTime":1734445800000,"name":"KraneShares MSCI All China Health Care Index ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-12-18","payableDate":"2024-12-17","currency":"USD","dateTimestamp":1734411600000,"payDate":"2024-12-18"},{"date":"2023-12-18","symbol":"KURE","amount":0.112844,"announcedDate":"2023-12-15","type":"dividend","market":"US","newRecordDate":"2023-12-19","defaultRemindTime":1702909800000,"name":"KraneShares MSCI All China Health Care Index ETF","recordDate":"2023-12-20","payableDate":"2023-12-19","currency":"USD","dateTimestamp":1702875600000,"payDate":"2023-12-20"},{"market":"US","date":"2022-12-28","symbol":"KURE","amount":0.010399,"defaultRemindTime":1672237800000,"name":"KraneShares MSCI All China Health Care Index ETF","recordDate":"2022-12-30","payableDate":"2022-12-29","currency":"USD","type":"dividend","dateTimestamp":1672203600000},{"market":"US","date":"2021-12-29","symbol":"KURE","amount":4.053448,"defaultRemindTime":1640788200000,"name":"KraneShares MSCI All China Health Care Index ETF","recordDate":"2021-12-31","payableDate":"2021-12-30","currency":"USD","type":"dividend","dateTimestamp":1640754000000}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"KURE\",market:\"US\",,,undefined,":[{"executeDate":"2018-12-26","recordDate":"2018-12-27","paymentDate":"2018-12-28","value":0.039344,"currency":"USD"},{"executeDate":"2019-12-27","recordDate":"2019-12-30","paymentDate":"2019-12-31","value":0.057325,"currency":"USD"},{"executeDate":"2020-12-29","recordDate":"2020-12-30","paymentDate":"2020-12-31","value":0.000109,"currency":"USD"},{"executeDate":"2021-12-29","recordDate":"2021-12-30","paymentDate":"2021-12-31","value":4.053448,"currency":"USD"},{"executeDate":"2022-12-28","recordDate":"2022-12-29","paymentDate":"2022-12-30","value":0.010399,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"KURE\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"KURE\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1145981825","title":"Moderna's Personalized mRNA Vaccine Achieves First Success, Chinese Innovators Line Up","url":"https://stock-news.laohu8.com/highlight/detail?id=1145981825","media":"Deep News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1145981825?lang=en_us&edition=fundamental","pubTime":"2026-08-21 11:56","pubTimestamp":1787284582,"startTime":"0","endTime":"0","summary":"The success of Moderna's Phase 3 trial has delivered the first pivotal proof-of-concept that mRNA technology can work in oncology, redirecting market attention toward Chinese biotech firms actively...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["159646","KURE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660336292","title":"China's Simcere Pharmaceutical H1 Revenue Rises on Neuroscience, Autoimmune Drugs Strength","url":"https://stock-news.laohu8.com/highlight/detail?id=2660336292","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660336292?lang=en_us&edition=fundamental","pubTime":"2026-08-20 23:02","pubTimestamp":1787238137,"startTime":"0","endTime":"0","summary":"China's Simcere Pharmaceutical H1 revenue rises on neuroscience, autoimmune drugs strengthOverviewChina pharmaceutical maker's interim revenue grew 27.8% yr/yr for six months ended June 2026Net income","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260820:nL1N44H0N2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1951186391.HKD","SG9999004220.SGD","LU1993786604.SGD","LU1960683339.HKD","BK4567","LU0880133367.SGD","01093","IE00B543WZ88.USD","IE00BZ08YT58.USD","LU0067412154.USD","LU1226287529.USD","KURE","LU0689626769.HKD","LU0203345920.USD","BK1521","LU1328277881.USD","BK4588","LU0140636845.USD","LU1226287875.USD","LU0501845795.SGD","BK1583","LU0124676726.USD","LU1152091168.USD","IE00BZ08YS42.EUR","BK1515","LU0154245673.USD","LU2039709279.SGD","LU1008478684.HKD","BK4533","LU0154245756.USD","IE0008368742.USD","MADE","BK1191","BK4585","LU2463526074.USD","BK4149","LU0072913022.USD","IE00BZ08YR35.GBP","LU0057025933.USD","LU0289961442.SGD","02096","LU0511384066.AUD","IE00B5MMRT66.SGD","CMI","LU1152091754.HKD","IE00B031HY20.USD","LU1226288253.USD","HK0000165453.HKD","IE000M9KFDE8.USD","LU0289739343.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660678238","title":"Pharma Sector Doubles Down on AI Amid Hopes of Slashing Costs, Timelines","url":"https://stock-news.laohu8.com/highlight/detail?id=2660678238","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660678238?lang=en_us&edition=fundamental","pubTime":"2026-08-20 22:30","pubTimestamp":1787236225,"startTime":"0","endTime":"0","summary":"FACTBOX-Pharma sector doubles down on AI amid hopes of slashing costs, timelinesAug 20 (Reuters)-Pharmaceutical companies are increasingly turning to artificial intelligence to accelerate research and","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260820:nL4N44H10I:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2750360997.AUD","LU3187612489.SGD","LU0310800379.SGD","LU1803068979.SGD","LU0738911758.USD","LU1697837992.HKD","IE00B19Z9505.USD","LU2272731782.SGD","LU2896262040.SGD","IE00BDRTCR15.USD","LU0894486033.HKD","LU1323610961.USD","BK4554","INCY","LU0476273544.USD","SG9999018857.SGD","LU0158827948.USD","LU0289961442.SGD","LU0323240290.USD","SMH","LU2129689605.HKD","LU0965509010.AUD","BK4598","LU1720051017.SGD","LU1815333072.USD","LU1037948897.HKD","BK4077","LU0786609619.USD","LU2322448791.USD","LU1019634622.SGD","LU2471134879.HKD","IE00B19Z3B42.SGD","NULC","BK4527","LU1023059063.AUD","TYLG","LU1732800096.USD","LU2473716301.USD","SKYY","LU0138981039.USD","LU0444973449.USD","SG9999014575.USD","IE00BN8TJ469.HKD","BK4577","MSFT","USD","LU1670627923.USD","LFGY","LU0109394709.USD","LU0114720955.EUR","LU0353189680.USD","IE00BMPRXQ63.HKD","LU0171293334.USD","LU2083900584.USD","LU1718418525.SGD","ILDR","LU2133065610.SGD","LU2065170008.USD","VGT","LU0266013472.USD","IE00BK4W5L77.USD","KURE","LU0079474960.USD","SG9999014880.SGD","SMHX","LU0784385170.HKD","LU0052756011.USD","IE0009G5SDU7.USD","ESLG","LU1400636657.SGD","LU1993786604.SGD","LU2750360641.GBP","NVDO","CQTM","LU0499090636.EUR","LU1366333091.USD","LU1291159041.SGD","LU0130102774.USD","LU1316542783.SGD","BK4614","LU2041044095.USD","LU0347712357.USD","LU1235295455.SGD","LU2168564495.EUR","LU2091194634.USD","BK4121","LU2298321311.HKD","LU0820561909.HKD","IYH","BK4543","IE0004445015.USD","LU1051770623.HKD","LU1670710588.SGD","LU0210528500.USD","LU2242650005.HKD","LU0823434740.USD","HK0000819398.USD","LU1267930730.SGD","IE00BWXC8680.SGD","LU0912757837.SGD","LU1674673691.USD","LU1084165304.USD","LU0985481810.HKD","LU2097829019.USD","IE00BMPRXR70.SGD","LU1823568750.SGD","IE00BQXX3C00.GBP","NVDS","LU0097036916.USD","LU1923622291.USD","IE00B775SV38.USD","LU2125909759.SGD","LU1564329115.USD","LU0353189763.USD","LU1144417596.USD","LU1868836591.USD","LU0640478417.SGD","LU1863844749.USD","BK1521","BK4568","IE00BZ08YR35.GBP","LU1153584641.USD","SGXZ57979304.SGD","IE00B4R5TH58.HKD","METV","LU2362540622.SGD","LU1226287529.USD","LU1228905540.USD","LU1935042215.USD","LU0471298694.HKD","BK4504","LU0642271901.SGD","LU0827474353.SGD","LU0708994859.HKD","BK4561","LU1814569148.SGD","IE0008368742.USD","LU2360107168.USD","LU0820562030.AUD","SG9999004303.SGD","LU1188199696.SGD","LU1261432733.SGD","LU0238689110.USD","FTXH","LU1934455194.USD","BK4559","LU0823414478.USD","LU1043141396.HKD","LU0203345920.USD","IE00BFXG1179.USD","HRTS","IE0000B7K699.USD","LU0792757196.USD","BK4528","LU0823416689.USD","SDGR","SG9999001077.SGD","LU0997586432.USD","LU1951198990.SGD","LU2271345857.HKD","LU1868836757.USD","LU0345768740.USD","BK4573","IE00BZ08YT58.USD","LU1366192091.USD","XDAT","BK4612","LU1093756325.SGD","LU1642822529.SGD","LU1196500208.SGD","IE00B031HY20.USD","LU1035775433.USD","IE00BKVL7J92.USD","LU0345770993.USD","LU0234572021.USD","LU0456855351.SGD","LU2077746001.SGD","IE00BZ199S13.USD","SG9999001176.USD","LU0976567544.SGD","IE00BZ1G4Q59.USD","LU1564329032.USD","SGXZ44715902.SGD","LU0251132253.USD","LU1267930573.SGD","LU1003077747.HKD","LU0390134368.USD","LU0879622024.SGD","LU0069063385.USD","LU1066051811.HKD","LU0477156797.USD","LU2293690249.USD","RSPS","LU1935042991.SGD","SLP","IE0009355771.USD","IE00BD6J9T35.USD","LU1778281490.HKD","LU2381873111.SGD","LU2272731600.USD","LU0787776722.HKD","LU1691799644.USD","LU2471134796.USD","BK1617","BK4550","IE00BLSP4239.USD","LU1181866309.USD","NVDQ","LU0289960550.SGD","AZN.UK","LU0256863811.USD","LU0494093205.USD","LU1066051498.USD","LU2039709279.SGD","LU1232071149.USD","LU0871640123.AUD","LU2106854487.HKD","AIFD","LU2191332357.HKD","GOOX","LU2125154935.USD","LU2430703095.HKD","LU2471134952.CNY","LU1974910355.USD","LU2210150020.SGD","IE000M9KFDE8.USD","LU2125909247.SGD","2NVD.UK","LU0496365809.HKD","FHLC","SG9999003800.SGD","IE0034235295.USD","LU0950375773.USD","LU2362541513.USD","LU1989771016.USD","LU0187121727.USD","LU0306806265.USD","LU1057294990.SGD","LU2089984988.USD","BK4581","LU2999663052.SGD","LU2404859741.USD","IE00B3S45H60.SGD","XLV","SHOC","LU0047473722.SGD","LU1670711040.USD","BK4196","BK4534","SG9999015358.SGD","IE00BHPRN162.USD","LU0048584097.USD","LU1989772923.USD","GB00B4LPDJ14.GBP","LU1623119135.USD","LH","LU0109391861.USD","BK4587","LU0154236417.USD","IE00BYQQ9H92.USD","GOOP","LU0265550946.USD","SGXZ23171101.USD","LU0672654240.SGD","SG9999017495.SGD","IE00BFTCPJ56.SGD","SG9999015952.SGD","LU0920840948.USD","LU1670711123.USD","LU0887340254.USD","LU0143551892.USD","LU1983260115.SGD","LU0708995401.HKD","IE00B19Z3581.USD","LU2539964713.USD","IE000SO60NU8.SGD","VOX","IQV","LU1548497426.USD","BK4167","LU2456880835.USD","BK4097","KVUE","LU1883839398.USD","LU1934455277.USD","LU0237698245.USD","WISE","LU1923622614.USD","LU0943347566.SGD","LU0784385840.USD","IE0002270589.USD","3NVD.UK","SMSFTmain","LU0171276677.USD","LU1019632923.USD","LU1037948541.HKD","LU1064131342.USD","LU1064927863.SGD","LU1852331112.SGD","LU2237443895.HKD","LU0006306889.USD","CHAT","LU0098860793.USD","SG9999015945.SGD","LU0251142724.SGD","BK4514","BK5011","LU0795875086.SGD","IETC","LU1153585028.USD","LU1815336760.USD","LU0208291251.USD","LU1674673428.USD","LU1046234339.USD","LU1121112475.USD","LU1061106388.HKD","IE00BKPKM429.USD","LU2954938101.SGD","HK0000914660.USD","IE00B1BXHZ80.USD","LU0127658192.USD","GOOW","LU0985320562.USD","NVDX","CHPX","LU0354030511.USD","LU2092937148.SGD","BK4574","BK4535","LU0289739343.SGD","IE00BLSP4452.SGD","WDNA","LU1066051225.USD","LU2602419157.SGD","LU2095319765.USD","LU2468319806.SGD","LU1923623000.USD","LU1228905037.USD","LU2242649171.HKD","LU2063271972.USD","LU1032955483.USD","LU1280957306.USD","LU2294711713.HKD","LU2458330243.SGD","IE00BQXX3D17.EUR","LU0795875169.SGD","TTXU","LU2125909593.SGD","LU0511384066.AUD","LU0823421333.USD","IE00BJJMRY28.SGD","GNOM","THMR","IE00BDGV0183.EUR","LU0316494557.USD","IE000WAW04H5.SGD","LU1935043536.SGD","TMED","LU2324357040.USD","SG9999014559.SGD","LU2168564149.EUR","LU0889565080.SGD","IE00BQXX3F31.USD","LLYX","LU0215105999.USD","LU0477156953.USD","LU0072461881.USD","BK4567","LU2360106947.USD","LU0323591593.USD","NVD3.UK","LU0859254822.USD","ILMN","IE00B4YYXB79.USD","IE000ITXATA3.USD","LU2023250504.SGD","LU0256863902.USD","HK0000304797.USD","LU2125154778.USD","LU1839511570.USD","LU1629891620.HKD","LU1941712348.USD","LU1868837136.USD","LU2746668974.SGD","LU0354030438.USD","XLK","LU0133085943.USD","LU0170899867.USD","LU2491050071.SGD","SOXX","GGLS","AGNG","LU0823414551.USD","LU0174119429.USD","LU0868494708.USD","LU0972486137.USD","CLSE","LU0308772762.SGD","LU0965509101.SGD","LU1633808545.USD","LU2244417387.USD","LU1989773731.SGD","LU0128525689.USD","LU2764262908.HKD","LU1821325948.USD","IDNA","LU1894683348.USD","SOXQ","LU1941712264.USD","LU2168564222.USD","GXPC","IE0009356076.USD","LU2065171311.SGD","LU0963555726.SGD","LU1880398471.USD","LU2236285917.USD","LU2452424414.USD","LU1670628061.USD","HK0000532082.HKD","FDTX","LU0980610538.SGD","LU0314104364.USD","LU2129689431.USD","TDIV","LU2097344357.USD","LU1863844665.USD","LU0823417653.USD","LU0053666078.USD","LU2462591350.SGD","GOOGL","LU0310799852.SGD","LU1201861165.SGD","LU0321505868.SGD","LU1951200564.SGD","SG9999015986.USD","XLC","NVDS.UK","LU0788109477.HKD","LU0823399737.USD","LU2860962120.EUR","LU1435385759.SGD","LU0048573561.USD","LU1059921491.USD","LU1551013425.SGD","SG9999002224.SGD","SG9999014906.USD","LU1829250122.USD","LU0994945656.USD","LU0082616367.USD","LU0057025933.USD","LU2111349929.HKD","SG9999001176.SGD","LU1582987324.SGD","LU2505996509.AUD","LU1861220033.SGD","LU0757359954.USD","LU1506573853.SGD","LU0321505439.SGD","LU1226287792.SGD","LU2023250843.SGD","LU0979878070.USD","GAMR","LU2764263039.SGD","BK4599","LU0175139822.USD","BK4602","SG9999018865.SGD","IE00BJTD4N35.SGD","LU1989772840.SGD","LU1221951046.USD","TRUC","LU1116320737.USD","LU2505996681.GBP","LU2237438978.USD","LU1670756490.USD","LU1813983027.USD","LU2092937221.SGD","MSFL","GLAM","IE0004445239.USD","LU2552382058.USD","PAWZ","LU0683600562.USD","LU0964806797.USD","LU1170363599.USD","LU2087621335.USD","LU0210533765.USD","LU1202635105.USD","LU1989764748.USD","LU2458330169.SGD","LU0096364046.USD","LU0345774631.USD","LU0417517546.SGD","LU2360032135.SGD","SG9999013999.USD","LU0203347892.USD","LU0198837287.USD","LU1400636574.HKD","IE0001KFT4U8.USD","EFIV","LU2237957902.USD","LU0158827781.USD","CMAG","LU0106261372.USD","BK4007","LU0348723411.USD","LU2092627202.USD","IE000YTNTUN2.SGD","NVD","NVDL","LU2543165471.USD","LU0823417737.USD","IE0003U64NQ7.SGD","LU2931357623.SGD","NVDD","LU2237443978.SGD","LU0757432116.USD","LU0820561818.USD","LU1008478684.HKD","NVDG","LU2087625088.SGD","NVYY","IHE","LU0857590862.USD","LU1496350502.SGD","LU0276348264.USD","LU0077335932.USD","LU0310800965.SGD","LU0553294199.USD","LU1078025761.USD","LU0689626769.HKD","LU0251131958.USD","IE0005OL40V9.USD","LU1791710582.SGD","LU2756315664.SGD","MSFU","LU2394011477.USD","LU1242518857.USD","LU1868836914.USD","KD","LU0426412945.USD","LU0823434583.USD","LU1880407132.USD","LU2100268510.USD","PJP","BK4576","IE00BYXW3230.USD","LU2286300806.USD","LU2089283258.USD","IE00BFSS8Q28.SGD","LU2129689514.USD","SGXZ81514606.USD","LU1015430645.USD","LU1429558221.USD","LU1267930227.SGD","IE00BJJMRZ35.SGD","LU0029874061.USD","IE0034235303.USD","BK1515","LU2213496289.HKD","BK4549","LU2506952170.USD","IE00B42XCP33.USD","LU0203202063.USD","LU1236620750.USD","GDOC","LU2028103732.USD","IE000Q6AESB8.SGD","LU2471134523.USD","LU0689472784.USD","LU2430703251.USD","LU0661504455.SGD","LU1992135472.HKD","LU0124676726.USD","LU1496350171.SGD","LU0823421416.USD","LU2272731865.HKD","LU2322448957.HKD","LU1934455863.HKD","EKG","MEDX","LU0109392836.USD","SG9999014914.USD","SGXZ80539844.SGD","LU0861579265.USD","LU1226287875.USD","LU0345768153.USD","LU1487256676.USD","LU1196032939.SGD","CANC","LU1066053197.SGD","LU2357305700.SGD","LU0289941410.SGD","LU2249611893.SGD","LU0575583348.USD","LU0545039389.USD","LU2275660780.HKD","LU0095938881.EUR","LU0724617625.USD","BK4551","LU0426417589.USD","IE00B775H168.HKD","LU1244550577.SGD","LU1582986433.USD","LU0889566641.SGD","IE00BGHQF631.EUR","IE00BJTD4V19.USD","LU0949170772.SGD","GOU","LU1894683264.USD","LU2065169927.USD","LU0385154629.USD","LU1328277881.USD","LU2102340556.USD","LU2764263203.CNY","BMED","LU1989763005.USD","PPH","LU0029864427.USD","LU2097344431.USD","LU1732799900.SGD","LU1301847155.USD","LU2054465674.USD","SG9999014542.SGD","CNEQ","LU2592432038.USD","LU1935042488.USD","SG9999004220.SGD","SGXZ99366536.SGD","LU0784383803.USD","LU1712237335.SGD","VT","LU0094547139.USD","LU0225283273.USD","BK4525","LLY","MEDI","MSFX","SPTE","LU0444971666.USD","JNJ","LU2404859667.USD","IE0009354923.USD","IE0034235188.USD","LU0080751232.USD","LU2506951958.HKD","LU0345770308.USD","MSFW","LU0122379950.USD","LU2089985449.USD","LU0969580561.USD","LU2293690082.USD","LU1880407215.USD","LU0882574055.USD","IE00BFSS7M15.SGD","LU0130103400.USD","LU0889565833.HKD","GOOY","HK0000320264.USD","LU1791710400.SGD","LU1861127337.USD","LU1929549753.HKD","ANV","IE00BVYPNW00.USD","LU0526926950.USD","IE00BJLML261.HKD","NVII","LU2506951792.HKD","LU1699723380.USD","IE00BK4W5M84.HKD","BMY","LU0210536198.USD","LU0784384876.USD","LU0742534661.SGD","LU1481600234.SGD","HK0000306685.HKD","ELIS","LU0395794307.EUR","BK4548","LU0326950275.SGD","LU0965508806.USD","LU0345769128.USD","LU2326559502.SGD","LU2746668461.USD","AGOX","IE000KEQY171.SGD","JDOC","LU1551013342.USD","LU0466842654.USD","TRUH","IE00B19Z8W00.USD","LU1355424745.HKD","LU2355687059.USD","BK4592","LU1201861249.SGD","SG9999015341.SGD","BK4608","LU2108987350.USD","LU0011850046.USD","LU2125909916.SGD","LU0070302665.USD","LU0225771236.USD","LU2403377893.USD","LU1069347547.HKD","LU1226288253.USD","HK0000304805.HKD","LU1917777945.USD","LU0949170426.SGD","SG9999011175.SGD","LU0072462426.USD","LU0920783379.SGD","LU2552382215.SGD","LU2357125470.USD","LU2462591277.SGD","LU1119994496.HKD","LU1003076772.USD","LU0211331839.USD","02228","BK4579","BK4605","GGLL","IXN","LU1242518931.SGD","ARTY","LU2023251221.USD","LU0140636845.USD","LU0690374615.EUR","AIPI","LU2720916845.USD","BK4134","LU2114397693.USD","LU1430594728.SGD","LU2357627491.SGD","LU2491050154.USD","IE00BKPKM643.USD","LU0882574139.USD","IE000MB6IJN5.SGD","IE00B7SZLL34.SGD","LU0757359368.USD","SG9999001424.SGD","NVIW.SI","HK0000320223.HKD","VHT","LU0067412154.USD","LU2461242641.AUD","LU2242652126.USD","LU2362541273.HKD","LU2211815571.USD","IE00B7SZL793.SGD","IE00BFXG0V08.USD","LU0267386448.USD","LU2361044865.SGD","BK1191","SOXY","LU0964807845.USD","NVDU","SG9999000418.SGD","LU0006061336.USD","LU1979441026.SGD","LU2237957811.SGD","IE000W1ABFV2.USD","LU0274383776.USD","ELIL","LU0056508442.USD","IE00B66KJ199.SGD","SNPE","LU2361044949.HKD","LU1221951129.SGD","LU0957799991.USD","LU1046421795.USD","NVD2.UK","IE00BN29S564.USD","IE000BZT7R73.USD","LU1670710661.SGD","LU0072913022.USD","LU0471298777.SGD","LU0345777147.USD","LU1645745479.HKD","LU1951186391.HKD","IE0031619046.USD","SG9999002232.USD","BK4141","LU1235294995.USD","LU0320765992.SGD","IE00BSNM7G36.USD","LU2347655073.USD","LU1093756168.USD","LU0880133367.SGD","LTL","LU2237443382.USD","SG9999014898.SGD","LU2065171402.SGD","IE00B3M56506.USD","BK4538","LU0314109678.HKD","LU1226288170.HKD","LU1983299246.USD","LU1988902786.USD","LU0345777659.USD","LU1303367103.USD","GB00B4QBRK32.GBP","LU1273509221.SGD","LU2552382132.HKD","ABFL","SNVDAmain","LU0203201768.USD","LU1721428933.USD","NVDW","LU1145028129.USD","LU2487616109.SGD","MRK","BK4530","FTEC","SGXZ31699556.SGD","OZEM","LU0960981461.USD","SGXZ51526630.SGD","BK4566","DIPS","IE00BJJMRX11.SGD","LU0545562505.USD","LU0965509283.SGD","LU1035773651.USD","LU1868837300.USD","LU1481599808.USD","LU1914381329.SGD","LU2237443622.USD","LLYZ","SG9999001440.SGD","JGRO","LU1074936037.SGD","LU1571399168.USD","BK4183","LU2417539215.USD","LU1236620834.HKD","LU0960925559.SGD","LU2237443465.HKD","LU2047632596.USD","HK0000914686.HKD","BK4139","IE00B4JS1V06.HKD","LU2413666699.HKD","MHIP","LU0211327993.USD","IE00B5949003.HKD","LU2756315318.SGD","LU0211328371.USD","IE00B5MMRT66.SGD","LU2279689827.SGD","IE00B5TLWC47.USD","LU1244550494.USD","LU0719512351.SGD","LU1807302812.USD","NVDA","LU0058720904.USD","LU0265550359.USD","LU0726765562.USD","FAI","LU2430703178.SGD","LU0432979614.USD","ESUM","BK1141","LU1803068623.USD","LU1935043023.USD","LU1104425308.USD","LU3102509885.SGD","TRFK","IE00BMPRXN33.USD","LU0320765489.SGD","LLII","LU1267930490.SGD","LU2112291526.USD","LU2360108059.USD","BK4532","LU1960683339.HKD","LU2247934214.USD","LU0957791311.USD","SG9999015978.USD","LU0889565916.HKD","SNVD.UK","LU2023250330.USD","07388","TEK","LU2210149790.SGD","LU1861215975.USD","IE00B19Z8X17.USD","IE00BFMHRM44.USD","LU0061474705.USD","LU0061474960.USD","LU2420271590.USD","LU2148611432.USD","LU0557290698.USD","IXJ","LU0345769631.USD","LU0323239441.USD","LU0128525929.USD","LU1334329650.SGD","IE00B3PB1722.GBP","IE00BJT1NW94.SGD","IE00B543WZ88.USD","LU2347655156.SGD","HK0000306701.USD","LU2361045086.USD","IE00B7KXQ091.USD","LU2413666426.HKD","LU1162221912.USD","LU2506952097.USD","LU0345774391.USD","LU2265009873.SGD","MSFD","LU2242646821.SGD","IE000F7OJYX1.SGD","LU0096362180.USD","LU0211326839.USD","LU0312595415.SGD","LU2098885051.SGD","BK4585","BK4516","SG9999014567.USD","TTEQ","LU2360106780.USD","LU1720051108.HKD","LU1582986359.USD","LU1585245621.USD","BK4529","LU2168564065.EUR","LU2250418816.HKD","IE00BZ08YS42.EUR","LU0107464264.USD","LU0957808578.USD","USXF","IE00B3T34201.USD","LU1400636491.USD","IE0002141913.USD","LU0342679015.USD","LU1564329628.SGD","LU0061475181.USD","LU0690374961.EUR","LU0162691827.USD","LU0315179316.USD","LU1804176565.USD","LU0320765646.SGD","LU2462157665.USD","LU2596442595.SGD","RNA","IE00BKDWB100.SGD","LU0648001328.SGD","LU2089284900.SGD","GB00BDT5M118.USD","IE00BVYPNV92.GBP","LU1043141123.HKD","PFE","LU0501845795.SGD","LU0289739699.SGD","LU1152091168.USD","THNR","IGV","LU0130517989.USD","BK4533","LU0149725797.USD","LU0070217475.USD","HEAL","LU2637965513.SGD","ROM","LU0472753341.HKD","LU1116320901.HKD","LU1992135399.USD","LU0211326755.USD","HK0000165453.HKD","LU0234570918.USD","LU1069344957.HKD","LU1244550221.USD","RXL","IE00B1XK9C88.USD","LU0157215616.USD","LU2264538146.SGD","LU0047473722.EUR","LU2491049909.HKD","MSFO","LU0640476718.USD","LU1152091754.HKD","IE0004086264.USD","IE00B3SWFQ91.USD","LU0314106906.USD","LU1564329461.SGD","LU0528227936.USD","07788","MSFY","LU0128526141.USD","LU0868494617.USD","LU0302445910.USD","03165","LU2433249047.HKD","NVDY","LU0081259029.USD","IE00BDCRKT87.USD","LU0942090050.USD","GNMX","LU2506951875.HKD","LU2290526834.HKD","BK4588","LU0130518102.USD","LU1880398554.USD","LU2237443549.SGD","NVDB","LU0997586515.USD","LU1032466523.USD","LU2463028550.USD","LU1267930813.SGD","LU1582987597.SGD","FCOM","IE0004091025.USD","LU0225284248.USD","BK4503","CURE","LU1127390331.HKD","LU1989764664.SGD","LU0306807586.USD","IE00B2B36J28.USD","LU0648000940.SGD","LU1340139317.AUD","BK4505","IE00BBT3K403.USD","LU0894485498.HKD","LU0320765059.SGD","OGIG","01093","LU2168563687.JPY","IE00B19Z4B17.USD","IE0008369823.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1147807009","title":"Southbound Capital Daily: Net Selloff Hits HK$10.41B, Alibaba Draws Mainland Buying Pre-Earnings, Healthcare Stocks Split","url":"https://stock-news.laohu8.com/highlight/detail?id=1147807009","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1147807009?lang=en_us&edition=fundamental","pubTime":"2026-08-20 18:01","pubTimestamp":1787220104,"startTime":"0","endTime":"0","summary":"On August 20, the Hong Kong stock market witnessed southbound trading post a net selloff of HK$10.412 billion. Specifically, the Shanghai-Hong Kong Stock Connect recorded a net sell of HK$5.111...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0823397103.USD","IE0034224299.USD","LU0791590937.USD","LU0634319403.HKD","LU0039217434.USD","LU0307460666.USD","LU0228659784.USD","LU0293314216.USD","LU1282649067.USD","LU0054237671.USD","LU0049853897.USD","SG9999001689.USD","LU1868838027.USD","LU0359201885.HKD","LU1105468828.SGD","LU0043850808.USD","LU1439103000.SGD","LU0672654166.SGD","LU1504937902.USD","LU0890818403.SGD","LU1251922891.USD","LU0577902298.EUR","LU0051755006.USD","LU0417516571.SGD","LU0348827113.USD","LU0588545730.USD","LU0326950275.SGD","LU0106259558.USD","LU0181495838.USD","LU0708995153.HKD","LU0455707207.USD","LU0469268626.HKD","LU0348814723.USD","LU0417516738.SGD","LU1226287529.USD","LU1880383440.USD","SG9999001903.USD","LU0577902454.USD","LU0096374516.USD","KSTmain","LU1044874839.SGD","LU0648000940.SGD","LU0823039010.USD","SG9999002828.SGD","01093","LU0543330566.HKD","LU0831103253.SGD","LU0501845795.SGD","LU0345776255.USD","LU2097828557.USD","LU0868486357.SGD","LU0823413587.USD","CXSE","LU0650527681.SGD","LU1770036033.HKD","LU1880398471.USD","89988","SGXZ62798434.SGD","81024","LU1051769294.HKD","LU0143863784.USD","LU0531971595.HKD","LU0880133367.SGD","HK0000165453.HKD","07300","LU0048597586.USD","LU0605514214.HKD","LU0823041008.USD","LU0254981946.USD","LU0132412106.USD","LU2488822045.USD","LU0651947912.USD","IE00B031HY20.USD","LU0540923850.HKD","SG9999002463.SGD","LU0823426480.USD","LU0449515922.USD","BK1576","LU0819121731.USD","BK1618","IE00BPRC5H50.USD","HK0000286598.CNH","LU1224709979.USD","LU2778985437.USD","LU2152927971.USD","LU1794554557.SGD","IE00BZ08YR35.GBP","03419","LU0011963245.USD","LU1808992512.USD","LU1242518931.SGD","LU0784639295.USD","KWEB","LU0516423174.USD","LU1719994722.HKD","LU0898667661.SGD","LU1115378108.SGD","BK1142","BK1590","LU0197773160.USD","LU0823426308.USD","LU1152091754.HKD","LU1810669033.SGD","LU0348825331.USD","LU2097828631.EUR","LU1048588211.SGD","LU0228367735.SGD","LU0516422440.USD","LU0196878994.USD","LU0165289439.USD","LU0797268264.HKD","LU0762541174.USD","HK0000151867.HKD","LU0642271901.SGD","FDNI","SG9999014674.SGD","BK1575","LU0127658192.USD","LU2242644610.SGD","LU1303224171.USD","LU0823038988.USD","BK1586","LU0531970944.HKD","LU0456846285.SGD","LU1226288170.HKD","LU1880383366.USD","LU0348805143.USD","LU0396098781.USD","LU0067412154.USD","LU0862451837.USD","LU0979878070.USD","LU1655091459.SGD","LU0431992006.USD","LU0611395673.USD","03037","IE0008368742.USD","LU0052750758.USD","LU0607220059.USD","LU1956131251.USD","LU2357305700.SGD","LU0261950983.USD","LU1008478684.HKD","LU0197773673.USD","LU0541502299.USD","LU0315178854.USD","LU0348767384.USD","IE0008368304.USD","HK0000306701.USD","LU0359202008.SGD","LU2097829019.USD","BK1141","LU1282649141.HKD","LU2449936058.SGD","LU0918141887.USD","LU0588545490.SGD","LU0651946864.USD","LU1807302812.USD","LU0762542818.HKD","LU1211504680.USD","LU1366334578.USD","LU0862451753.SGD","BK1095","LU0477156797.USD","LU0054450605.USD","01024","LU2293587155.HKD","LU0164880469.USD","LU2476274720.SGD","03115","BK1588","LU0823413660.USD","LU0370786039.SGD","LU0130518102.USD","LU0831093199.SGD","LU0210526637.USD","LU1282648689.USD","LU0348788117.USD","LU0117841782.USD","IE00BMPRXR70.SGD","LU0169518387.USD","LU1196710864.SGD","LU1813983027.USD","LU0327786744.USD","LU1282651048.USD","LU1044876610.USD","LU2097828714.EUR","LU1201861165.SGD","LU1688375341.USD","SOCL","LU0348784397.USD","LU0348735423.USD","LU1868837565.USD","LU0211977185.USD","LU0572940350.SGD","09115","LU0173614495.USD","LU0048388663.USD","LU0106252389.USD","BK1610","LU0348783233.USD","BK1591","LU0244354667.USD","LU0593848301.USD","LU1568876335.HKD","LU1568876251.USD","LU0594300179.USD","LU0488056044.USD","07500","LU1981816686.USD","LU0320764243.SGD","LU0084288322.USD","LU1023057109.AUD","LU0164872284.USD","SG9999001093.SGD","LU0128522157.USD","LU1993786604.SGD","LU0918141705.HKD","SG9999006597.SGD","LU1515016050.SGD","LU0577902611.USD","LU1242518857.USD","LU0588546209.SGD","IE0032431581.USD","LU0640798160.USD","LU0359201612.USD","LU1720051108.HKD","LU1880398554.USD","LU0231483743.USD","LU0072913022.USD","LU0821914370.USD","LU0140636845.USD","LU0210527791.USD","LU1831875114.USD","LU0106959298.USD","LU0456827905.SGD","LU0700851271.USD","LU0630378429.USD","LU2097828474.EUR","HK0000306685.HKD","HK0000320264.USD","LU0828237510.HKD","LU0417516902.SGD","IE00BZ08YS42.EUR","LU2257852520.SGD","LU0502904849.HKD","82800","LU1961090484.USD","LU0130103400.USD","IE00B5MMRT66.SGD","LU2087589342.USD","BK1584","LU0577902371.SGD","LU1226287792.SGD","LU0229945570.USD","LU0589944569.HKD","LU0823397285.USD","LU1720050803.USD","SG9999006514.SGD","HK0000107257.USD","07200","LU1323998911.USD","SG9999004220.SGD","LU0320764599.SGD","LU0143863198.USD","BK1501","IE00B0JY6N72.USD","01548","LU1188198961.HKD","BK1502","BK1515","LU0572939691.SGD","KURE","LU0543330483.HKD","HSI","LU0328353924.USD","LU0348766576.USD","LU0384037296.USD","BK1583","LU0608807946.USD","LU1282649810.SGD","LU0048580855.USD","LU1224444064.USD","SGXZ90724238.SGD","LU1152091168.USD","LU0577902538.SGD","LU0541501648.USD","LU0572944931.SGD","LU0329678170.USD","LU0516422952.EUR","SG9999000459.SGD","LU0235996351.USD","LU2476274308.USD","LU0029875118.USD","BK1608","LU0149534421.HKD","LU2125910849.SGD","LU0128522744.USD","LU3063872942.SGD","LU0737861772.HKD","LU0823040885.USD","LU0791591158.USD","IE00BMPRXN33.USD","LU0441854154.USD","LU0348783662.USD","LU0648948544.HKD","LU1282651121.HKD","SG9999002562.SGD","LU2294711473.HKD","BKF","LU0261947096.USD","LU1769817179.HKD","LU2226246903.HKD","LU0047713382.USD","SG9999001051.SGD","83115","LU1044875133.USD","LU0594300419.USD","LU2125910500.SGD","IE00B3M56506.USD","IE00BZ08YT58.USD","LU1366334651.USD","SG9999000327.SGD","LU0516423091.SGD","LU2045819591.USD","LU1642822792.SGD","LU1769817096.USD","LU0737861699.HKD","LU2039709279.SGD","LU1048596156.SGD","LU0630378692.HKD","LU0516422366.SGD","LU0320764755.SGD","LU1226288253.USD","LU0029874905.USD","LU1048484197.HKD","SGXZ86797644.SGD","LU1051768304.USD","LU0886674414.USD","LDEM","DRGN","LU1481107354.HKD","LU2399975544.HKD","SG9999001226.SGD","LU1328615791.USD","LU0287142896.SGD","HK0000320223.HKD","LU1951186391.HKD","LU0708995583.HKD","02800","LU0819123356.HKD","LU0865486749.SGD","IE0003895053.USD","LU0871576103.HKD","LU0463099449.HKD","LU1960683339.HKD","LU0149721374.USD","BK1615","LU0329678337.USD","BK1521","LU1548497426.USD","LU0588545904.SGD","LU0315179316.USD","LU0499858602.USD","LU0675040207.SGD","LU0561508036.HKD","LU1770034418.SGD","HBBD.SI","LU2097828805.USD","IE00B0169N27.USD","LU1316542783.SGD","IE0008369823.USD","LU0061477393.USD","LU0828237940.HKD","LU1720051017.SGD","LU0117844026.USD","LU0259732245.USD","LU0499858438.USD","LU0214875030.USD","LU0873338254.USD","LU0856984785.SGD","LU0163747925.USD","LU0345775950.USD","LU0608807433.USD","LU0449509016.USD","LU0072462343.USD","LU1226287875.USD","09988","LU0264606111.USD","LU0762540952.USD","LU0348816934.USD","BABA","IE00B543WZ88.USD","LU0251144936.SGD","BK1249","BK1517","LU0314109678.HKD","LU1328277881.USD","BK1191","LU0164865239.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660940244","title":"Hong Kong Stocks Rise on Thursday on Easing Bond Concerns, Tech Gains; CSPC Pharma Jumps 9%","url":"https://stock-news.laohu8.com/highlight/detail?id=2660940244","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660940244?lang=en_us&edition=fundamental","pubTime":"2026-08-20 16:41","pubTimestamp":1787215286,"startTime":"0","endTime":"0","summary":"Hong Kong stocks closed higher Thursday as a rebound in global bond markets eased investor concerns over rising yields.Technology shares also advanced, helping lift the broader market.The Hang Seng In","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0314109678.HKD","LU1226287792.SGD","LU1226287875.USD","LU1813983027.USD","HHImain","LU1008478684.HKD","01093","LU1152091168.USD","09115","IE0008368742.USD","IE00B5MMRT66.SGD","LU0072913022.USD","LU1960683339.HKD","513600","LU0501845795.SGD","07300","LU1226288170.HKD","IE0008369823.USD","IE00B031HY20.USD","03419","LU0326950275.SGD","HSI","02800","82800","MCHmain","SG9999004220.SGD","LU1807302812.USD","LU1993786604.SGD","BK1191","LU1226287529.USD","02833","IE00BZ08YR35.GBP","LU0067412154.USD","LU1226288253.USD","LU1328277881.USD","LU1951186391.HKD","HK0000165453.HKD","03037","07500","83115","BK1521","HSTECH","LU0880133367.SGD","KURE","IE00B543WZ88.USD","LU1152091754.HKD","IE00BZ08YT58.USD","MHImain","03115","IE00BZ08YS42.EUR","LU2039709279.SGD","BK1515","07200","LU0140636845.USD","LU0315179316.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1112972959","title":"CSPC Pharma Surges 15% as Moderna's mRNA Cancer Vaccine Hits Key Milestone","url":"https://stock-news.laohu8.com/highlight/detail?id=1112972959","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1112972959?lang=en_us&edition=fundamental","pubTime":"2026-08-20 16:00","pubTimestamp":1787212816,"startTime":"0","endTime":"0","summary":"Shares of CSPC Pharma (01093) jumped over 15% in morning trading, driven by the positive top-line results from the Phase III INTerpath-001 trial of Moderna's personalized mRNA cancer therapy,...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0314109678.HKD","LU1226287792.SGD","LU1226287875.USD","LU1813983027.USD","LU1008478684.HKD","01093","LU1152091168.USD","IE0008368742.USD","IE00B5MMRT66.SGD","LU0072913022.USD","LU1960683339.HKD","LU0501845795.SGD","LU1226288170.HKD","IE0008369823.USD","IE00B031HY20.USD","159646","LU0326950275.SGD","SG9999004220.SGD","LU1807302812.USD","LU1993786604.SGD","BK1191","LU1226287529.USD","IE00BZ08YR35.GBP","LU0067412154.USD","LU1226288253.USD","LU1328277881.USD","LU1951186391.HKD","HK0000165453.HKD","LU0880133367.SGD","BK1521","KURE","IE00B543WZ88.USD","LU1152091754.HKD","IE00BZ08YT58.USD","IE00BZ08YS42.EUR","LU2039709279.SGD","BK1515","LU0140636845.USD","LU0315179316.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660926405","title":"Norway's Vistin Pharma Q2 Revenue Falls on Currency Impact","url":"https://stock-news.laohu8.com/highlight/detail?id=2660926405","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660926405?lang=en_us&edition=fundamental","pubTime":"2026-08-20 13:54","pubTimestamp":1787205278,"startTime":"0","endTime":"0","summary":"Norway's Vistin Pharma Q2 revenue falls on currency impactOverviewNorway pharmaceutical maker's Q2 revenue fell yr/yr due to stronger NOK despite 8% sales volume growthQ2 EBITDA and net profit decline","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260820:nL1N44H068:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BZ08YS42.EUR","LU1960683339.HKD","LU2039709279.SGD","LU0326950275.SGD","LU1807302812.USD","BK1515","LU0314109678.HKD","01093","IE00BZ08YR35.GBP","LU1152091168.USD","IE0008368742.USD","LU0880133367.SGD","LU1993786604.SGD","IE00B5MMRT66.SGD","BK1191","LU0315179316.USD","IE00BZ08YT58.USD","LU1226287529.USD","LU1226287792.SGD","LU1226287875.USD","IE00B031HY20.USD","KURE","LU0072913022.USD","BK1521","LU1008478684.HKD","LU0140636845.USD","SG9999004220.SGD","LU1226288170.HKD","IE0008369823.USD","LU1813983027.USD","LU1226288253.USD","LU1328277881.USD","LU0501845795.SGD","LU0067412154.USD","LU1152091754.HKD","IE00B543WZ88.USD","LU1951186391.HKD","HK0000165453.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1189336205","title":"CSPC Pharma (01093) Surges Over 12% After Interim Profit Jumps Nearly 1.4-Fold","url":"https://stock-news.laohu8.com/highlight/detail?id=1189336205","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1189336205?lang=en_us&edition=fundamental","pubTime":"2026-08-20 13:40","pubTimestamp":1787204412,"startTime":"0","endTime":"0","summary":"Shares of CSPC PHARMA (01093) climbed more than 12% following its interim results announcement, trading up 11.97% at HK$9.725 with turnover reaching HK$3.057 billion as of press time.On August 20 at...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2039709279.SGD","BK4588","LU1008478684.HKD","BK1521","LU0072913022.USD","LU1226288170.HKD","LU1993786604.SGD","VXUS","LU0501845795.SGD","01093","LU0067412154.USD","LU1152091168.USD","LU1226287792.SGD","LU0326950275.SGD","LU1807302812.USD","LU0315179316.USD","LU0880133367.SGD","LU1813983027.USD","IE00B5MMRT66.SGD","IE0008369823.USD","BK1515","IE0008368742.USD","LU1226287529.USD","LU1951186391.HKD","LU1226288253.USD","LU0314109678.HKD","IE00BZ08YT58.USD","LU0140636845.USD","LU1328277881.USD","IE00B031HY20.USD","LU1226287875.USD","SG9999004220.SGD","IE00B543WZ88.USD","IE00BZ08YS42.EUR","IE00BZ08YR35.GBP","KCAI","LU1152091754.HKD","LU1960683339.HKD","KURE","HK0000165453.HKD","BK1191","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660403439","title":"CSPC Pharmaceutical Hits 6-Month High on Profit, Dividend Surge","url":"https://stock-news.laohu8.com/highlight/detail?id=2660403439","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660403439?lang=en_us&edition=fundamental","pubTime":"2026-08-20 13:19","pubTimestamp":1787203167,"startTime":"0","endTime":"0","summary":"BUZZ-CSPC Pharmaceutical hits 6-month high on profit, dividend surge** Shares of CSPC Pharmaceutical Group1093.HKjump 17.1% to HK$10.17, their highest level since February 25** Stock on track for its biggest one-day pct gain since June 2012** Second-biggest percentage gainer on the benchmark Hang Seng Index.HSI, which gains 1.1%** Chinese pharmaceutical maker saidH1 profit attributablejumped 139% y/y with total revenue up 40% y/y driven by finished drugs growth** Co declares an interim dividend of HK$0.18 per share, up 28.6% from HK$0.14 each a year ago** YTD, stock up 16.9%, Hang Seng Biotech Index.HSBIOup 15.9%","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260820:nL1N44H05B:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BZ08YR35.GBP","LU1328277881.USD","LU1226287792.SGD","LU1813983027.USD","LU1152091754.HKD","IE00B543WZ88.USD","LU1993786604.SGD","BK1191","IE0008368742.USD","LU2039709279.SGD","IE00B5MMRT66.SGD","IE00BZ08YS42.EUR","KURE","LU0501845795.SGD","LU0072913022.USD","LU0067412154.USD","LU1951186391.HKD","LU0140636845.USD","LU0314109678.HKD","SG9999004220.SGD","LU1807302812.USD","LU1960683339.HKD","LU1226287529.USD","LU1226288170.HKD","BK1515","IE0008369823.USD","LU0326950275.SGD","IE00BZ08YT58.USD","BK1521","LU0315179316.USD","HK0000165453.HKD","LU1226287875.USD","01093","LU1226288253.USD","LU0880133367.SGD","IE00B031HY20.USD","LU1008478684.HKD","LU1152091168.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660403998","title":"CSPC Pharmaceutical's Attributable Profit More Than Doubles in H1; Shares Jump 14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2660403998","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660403998?lang=en_us&edition=fundamental","pubTime":"2026-08-20 13:09","pubTimestamp":1787202587,"startTime":"0","endTime":"0","summary":"CSPC Pharmaceutical Group  reported an over 139% jump in attributable profit for the first half of 2026 to 6.09 billion yuan from 2.55 billion yuan a year earlier, according to a Thursday Hong Kong bourse filing.Earnings per share for the six months ended June 30 climbed to 0.5336 yuan from 0.2229 yuan in the prior-year period.Revenue of the pharma company jumped 40.1% year on year to 18.6 billion yuan from 13.3 billion yuan.The company declared an interim dividend of HK$0.18 per share, payable on Nov. 10 to shareholders of record on Oct. 26.Shares of the company jumped nearly 14% in recent trade.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0326950275.SGD","LU1951186391.HKD","LU0072913022.USD","IE00B5MMRT66.SGD","HK0000165453.HKD","LU1152091168.USD","IE00BZ08YR35.GBP","BK1521","IE0008369823.USD","LU1813983027.USD","BK1515","SG9999004220.SGD","LU1226288253.USD","LU0501845795.SGD","LU1807302812.USD","IE00BZ08YT58.USD","IE0008368742.USD","LU1226287529.USD","LU0880133367.SGD","LU1226288170.HKD","IE00B543WZ88.USD","LU1226287875.USD","LU0314109678.HKD","LU1328277881.USD","LU1993786604.SGD","LU1008478684.HKD","IE00BZ08YS42.EUR","LU1960683339.HKD","FCA","BK1191","KURE","LU1226287792.SGD","LU1152091754.HKD","LU0140636845.USD","01093","LU2039709279.SGD","IE00B031HY20.USD","LU0315179316.USD","LU0067412154.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660906408","title":"CSPC Pharma FY26 H1 Profit Attributable to Shareholders More than Doubled to RMB 6.09 Billion; Revenue Rises 40.1% to RMB 18.59 Billion","url":"https://stock-news.laohu8.com/highlight/detail?id=2660906408","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660906408?lang=en_us&edition=fundamental","pubTime":"2026-08-20 12:19","pubTimestamp":1787199569,"startTime":"0","endTime":"0","summary":"CSPC Pharma FY26 H1 profit attributable to shareholders more than doubled to RMB 6.09 billion; revenue rises 40.1% to RMB 18.59 billionCSPC Pharmaceutical posted first-half revenue of RMB 18.59 billio","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260820:nNDL6XHzX9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B5MMRT66.SGD","LU0140636845.USD","LU1960683339.HKD","LU1993786604.SGD","BK1191","LU1226288253.USD","LU1152091754.HKD","01093","IE00BZ08YR35.GBP","LU0072913022.USD","LU0314109678.HKD","LU1226288170.HKD","LU0501845795.SGD","IE00B543WZ88.USD","LU0315179316.USD","LU0880133367.SGD","SG9999004220.SGD","LU1328277881.USD","IE0008369823.USD","IE0008368742.USD","LU1807302812.USD","LU1226287529.USD","IE00BZ08YS42.EUR","LU1813983027.USD","LU1152091168.USD","BK1521","LU1951186391.HKD","LU1226287792.SGD","KURE","LU2039709279.SGD","BK1515","LU1226287875.USD","IE00B031HY20.USD","LU0326950275.SGD","LU0067412154.USD","HK0000165453.HKD","IE00BZ08YT58.USD","LU1008478684.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660408970","title":"CSPC Pharmaceutical Group H1 Net Income Attributable RMB 6,094.2 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2660408970","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660408970?lang=en_us&edition=fundamental","pubTime":"2026-08-20 12:18","pubTimestamp":1787199533,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260820:nPLXV00X44:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU1951186391.HKD","LU1226288170.HKD","LU0501845795.SGD","LU1807302812.USD","LU1226288253.USD","LU1960683339.HKD","LU0315179316.USD","LU1328277881.USD","KURE","IE00B031HY20.USD","LU1226287529.USD","IE00BZ08YT58.USD","LU0072913022.USD","IE00BZ08YS42.EUR","IE0008368742.USD","BK1515","IE0008369823.USD","LU0314109678.HKD","LU1008478684.HKD","LU1152091168.USD","IE00B543WZ88.USD","LU1993786604.SGD","IE00B5MMRT66.SGD","BK1191","LU2039709279.SGD","LU1152091754.HKD","LU0067412154.USD","IE00BZ08YR35.GBP","LU0880133367.SGD","LU1813983027.USD","LU0140636845.USD","01093","SG9999004220.SGD","LU1226287792.SGD","LU0326950275.SGD","HK0000165453.HKD","BK1521","LU1226287875.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660140897","title":"CSPC Pharmaceutical Group - Interim Dividend of HK18 Cents Per Share for 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2660140897","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660140897?lang=en_us&edition=fundamental","pubTime":"2026-08-20 12:18","pubTimestamp":1787199533,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260820:nPLXV00X44:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1515","IE00BZ08YS42.EUR","LU1008478684.HKD","LU1807302812.USD","IE00B5MMRT66.SGD","LU0140636845.USD","LU0072913022.USD","LU1328277881.USD","IE0008368742.USD","LU0314109678.HKD","BK1191","LU0880133367.SGD","HK0000165453.HKD","LU1226288170.HKD","LU1960683339.HKD","LU0501845795.SGD","LU1993786604.SGD","SG9999004220.SGD","LU1226287875.USD","LU0326950275.SGD","LU1226287792.SGD","01093","BK1521","LU0315179316.USD","IE00B031HY20.USD","LU1226288253.USD","IE00BZ08YR35.GBP","LU1152091168.USD","LU2039709279.SGD","LU1951186391.HKD","IE00BZ08YT58.USD","LU0067412154.USD","LU1813983027.USD","IE0008369823.USD","IE00B543WZ88.USD","LU1152091754.HKD","LU1226287529.USD","KURE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1197259183","title":"Biotech Sector Surges as Moderna's Melanoma Vaccine Milestone Sparks Oncology and mRNA Repricing","url":"https://stock-news.laohu8.com/highlight/detail?id=1197259183","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1197259183?lang=en_us&edition=fundamental","pubTime":"2026-08-20 07:38","pubTimestamp":1787182701,"startTime":"0","endTime":"0","summary":"On August 20, the Nasdaq Biotechnology Index jumped 6.39%, marking its largest single-day gain in six years. Moderna soared 176.97%, adding $44 billion in market value, while Merck closed up 12.6%,...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1589","LU0128526141.USD","LU0348735423.USD","LU1242518857.USD","IE00B0JY6N72.USD","LU0456827905.SGD","BK1161","LU0516422440.USD","LU0572944931.SGD","LU0051755006.USD","LU2039709279.SGD","LU0052750758.USD","VXUS","LU0307460666.USD","LU0417516902.SGD","LU1880383366.USD","LU3063872942.SGD","LU0708995583.HKD","BK4585","LU0320764599.SGD","LU1794554557.SGD","KURE","LU0348825331.USD","BK1576","BK4588","LU0359201612.USD","LU0823426480.USD","01244","LU0823426308.USD","LU0588546209.SGD","LU0456846285.SGD","BK1521","LU0181495838.USD","KCAI","LU0359202008.SGD","BK1610","LU0029874061.USD","LU0039217434.USD","LU0043850808.USD","LU0417516738.SGD","LU0516422952.EUR","LU0856984785.SGD","LU1688375341.USD","LU1242518931.SGD","LU0326950275.SGD","LU0979878070.USD","LU0516423091.SGD","LU0516423174.USD","LU0140636845.USD","LU1720050803.USD","SG9999002463.SGD","WDNA","BK1141","LU0516422366.SGD","02269","LU0819121731.USD","SG9999002562.SGD","LU0327786744.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660244894","title":"Akeso (SEHK:9926) Could Be 47% Undervalued As China Approves Ivonescimab Use","url":"https://stock-news.laohu8.com/highlight/detail?id=2660244894","media":"Simply Wall St.","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660244894?lang=en_us&edition=fundamental","pubTime":"2026-08-19 22:20","pubTimestamp":1787149244,"startTime":"0","endTime":"0","summary":"Akeso (SEHK:9926) is back in focus after China’s National Medical Products Administration approved ivonescimab plus chemotherapy as a first-line treatment for advanced squamous non-small cell lung cancer.\nSee our latest analysis for Akeso.\nDespite the positive ivonescimab news, Akeso’s share price has come under pressure, with the stock down 12.54% over the past week and 21.18% year to date. At the same time, the 3 year total shareholder return of 185.76% and 5 year total shareholder return...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-9926/akeso-shares/news/akeso-sehk9926-could-be-47-undervalued-as-china-approves-ivo","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-9926/akeso-shares/news/akeso-sehk9926-could-be-47-undervalued-as-china-approves-ivo","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LU2476274308.USD","IE00BPRC5H50.USD","LU0417516571.SGD","LU0348767384.USD","LU2778985437.USD","09926","LU2399975544.HKD","LU2476274720.SGD","LU0348827113.USD","LU1961090484.USD","LU1794554557.SGD","LU0417516902.SGD","LU2488822045.USD","LU0417516738.SGD","BK1574","LU1720050803.USD","LU0634319403.HKD","LU0348735423.USD","BK1161","LU0348784397.USD","LU0348766576.USD","IE00B543WZ88.USD","KURE","LU0348825331.USD","IE00B5MMRT66.SGD","LU0348783233.USD","LU0540923850.HKD","LU0561508036.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660453474","title":"CSPC Pharmaceutical Group Stock Sheds 1.3% in Hong Kong, Underperforms Competitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2660453474","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660453474?lang=en_us&edition=fundamental","pubTime":"2026-08-19 16:33","pubTimestamp":1787128380,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of CSPC Pharmaceutical Group Ltd. slipped 1.3% to 8.69 Hong Kong dollars on what proved to be an all-around positive trading session for the Hong Kong stock market, with the Hang Seng Index rising 0.1% to 25495.07.The stock's fall snapped a two-day winning streak.CSPC Pharmaceutical Group Ltd. closed 25% below its 52-week high of HK$11.63, which the company achieved Sept. 9.The stock demonstrated a mixed performance when compared to some of its competitors, as Sino Biopharmaceutical Ltd. fell 0.1%, SSY Group Ltd. fell 0.6%, and United Laboratories International Holdings Ltd. fell 1.4%.Trading volume totaled 67.4 million shares, compared to the 50-day average of 92.1 million shares.Data source: Dow Jones Market Data, FactSet","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0880133367.SGD","IE00B5MMRT66.SGD","IE00B031HY20.USD","BK1515","IE00BZ08YT58.USD","LU1152091168.USD","LU1226287875.USD","LU1328277881.USD","KURE","LU0314109678.HKD","LU1226288253.USD","LU1807302812.USD","LU0315179316.USD","LU0326950275.SGD","LU0140636845.USD","LU1226287792.SGD","LU1951186391.HKD","IE00B543WZ88.USD","HK0000165453.HKD","LU1960683339.HKD","IE0008368742.USD","LU1226288170.HKD","01093","LU1993786604.SGD","BK1191","IE00BZ08YR35.GBP","LU1008478684.HKD","LU1152091754.HKD","LU0072913022.USD","LU0501845795.SGD","IE0008369823.USD","BK1521","LU0067412154.USD","LU1226287529.USD","IE00BZ08YS42.EUR","SG9999004220.SGD","LU1813983027.USD","LU2039709279.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660445379","title":"Wuxi Biologics (Cayman) Stock Falls 1.4% in Hong Kong","url":"https://stock-news.laohu8.com/highlight/detail?id=2660445379","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660445379?lang=en_us&edition=fundamental","pubTime":"2026-08-19 16:33","pubTimestamp":1787128380,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Wuxi Biologics  Inc. slipped 1.4% to 47.90 Hong Kong dollars on what proved to be an all-around favorable trading session for the Hong Kong stock market, with the Hang Seng Index rising 0.1% to 25495.07.The stock's fall snapped a two-day winning streak.Wuxi Biologics  Inc. closed 2.2% below its 52-week high of HK$49.00, which the company achieved Aug. 18.Trading volume totaled 32.0 million shares, compared to the 50-day average of 35.0 million shares.Data source: Dow Jones Market Data, FactSet","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0029874061.USD","LU0823426308.USD","LU0823426480.USD","LU0516422440.USD","BK1589","LU0819121731.USD","LU1794554557.SGD","LU0039217434.USD","LU1720050803.USD","LU0348735423.USD","LU0979878070.USD","LU0572944931.SGD","BK1576","LU1880383366.USD","BK1521","LU0516422952.EUR","LU0417516902.SGD","LU0588546209.SGD","BK1610","BK1141","LU0140636845.USD","LU0417516738.SGD","LU0708995583.HKD","LU2039709279.SGD","LU0043850808.USD","LU0516423174.USD","LU3063872942.SGD","LU0181495838.USD","LU1242518857.USD","LU0348825331.USD","LU0320764599.SGD","KURE","LU0326950275.SGD","LU0856984785.SGD","LU1242518931.SGD","LU0327786744.USD","SG9999002463.SGD","LU0128526141.USD","LU0456827905.SGD","02269","LU0051755006.USD","IE00B0JY6N72.USD","LU0307460666.USD","LU0359202008.SGD","LU1688375341.USD","SG9999002562.SGD","LU0052750758.USD","LU0359201612.USD","LU0516422366.SGD","LU0456846285.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660480614","title":"Does FDA-Backed Mpox mRNA Trial and AstraZeneca Tie-Up Recast the Bull Case For CSPC (SEHK:1093)?","url":"https://stock-news.laohu8.com/highlight/detail?id=2660480614","media":"Simply Wall St.","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660480614?lang=en_us&edition=fundamental","pubTime":"2026-08-19 13:12","pubTimestamp":1787116367,"startTime":"0","endTime":"0","summary":"CSPC Pharmaceutical Group recently reported three developments: U.S. FDA approval to begin clinical trials for its mpox mRNA vaccine, a US$10,000,000 milestone payment from AstraZeneca tied to their small-molecule collaboration, and a joint venture with AstraZeneca to build a biologics manufacturing facility in Shijiazhuang, China.\nTogether, these moves expand CSPC’s innovative vaccine and drug pipeline while pushing its manufacturing and quality systems further onto the global stage.\nWe’ll...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-1093/cspc-pharmaceutical-group-shares/news/does-fda-backed-mpox-mrna-trial-and-astrazeneca-tie-up-recas","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-1093/cspc-pharmaceutical-group-shares/news/does-fda-backed-mpox-mrna-trial-and-astrazeneca-tie-up-recas","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["IE00BZ08YS42.EUR","LU1960683339.HKD","LU2039709279.SGD","BK4588","LU0326950275.SGD","LU1807302812.USD","BK1515","LU0314109678.HKD","01093","IE00BZ08YR35.GBP","LU1152091168.USD","IE0008368742.USD","LU0880133367.SGD","LU1993786604.SGD","IE00B5MMRT66.SGD","BK1191","LU0315179316.USD","IE00BZ08YT58.USD","LU1226287529.USD","LU1226287792.SGD","LU1226287875.USD","IE00B031HY20.USD","LABU","KURE","BK4585","LU0072913022.USD","BK1521","LU1008478684.HKD","LU0140636845.USD","SG9999004220.SGD","LU1226288170.HKD","IE0008369823.USD","LU1813983027.USD","LU1226288253.USD","LU1328277881.USD","LU0501845795.SGD","LU0067412154.USD","LU1152091754.HKD","IE00B543WZ88.USD","LU1951186391.HKD","HK0000165453.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660494056","title":"Innovent Biologics (SEHK:1801), Why Is It Back In The Spotlight?","url":"https://stock-news.laohu8.com/highlight/detail?id=2660494056","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660494056?lang=en_us&edition=fundamental","pubTime":"2026-08-19 00:24","pubTimestamp":1787070276,"startTime":"0","endTime":"0","summary":"Innovent Biologics (SEHK:1801) caught investor attention after reporting product revenue of over CN¥4.3b for Q2 2026 and more than CN¥8.2b for the first half, supported by its dual engine growth strategy.\nSee our latest analysis for Innovent Biologics.\nThose revenue headlines have arrived alongside firm share price momentum, with Innovent Biologics delivering a 30 day share price return of 8.66% and a 90 day share price return of 21.73%, while the three year total shareholder return of...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-1801/innovent-biologics-shares/news/innovent-biologics-sehk1801-why-is-it-back-in-the-spotlight","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-1801/innovent-biologics-shares/news/innovent-biologics-sehk1801-why-is-it-back-in-the-spotlight","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LU1969619763.USD","HK0000165453.HKD","DCF","LU2097828557.USD","LU0455707207.USD","LU2242644610.SGD","LU2097828474.EUR","KURE","LU2097828714.EUR","01801","LU0463099449.HKD","LU2097828805.USD","LU2097828631.EUR","LU0502904849.HKD","LU2328871848.SGD","LU0244354667.USD","LU2488822045.USD","BK1583","BK1589","LU0326950275.SGD","LU1188198961.HKD","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660951444","title":"CSPC Pharma Says NMPA Accepts NDA for KN026 and Hb1801 for Advanced Breast Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2660951444","media":"Reuters","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660951444?lang=en_us&edition=fundamental","pubTime":"2026-08-18 23:22","pubTimestamp":1787066521,"startTime":"0","endTime":"0","summary":"BRIEF-CSPC Pharma Says NMPA Accepts NDA For KN026 And HB1801 For Advanced Breast CancerAug 18 (Reuters)-CSPC PHARMACEUTICAL GROUP LIMITED1093.HK:NMPA ACCEPTS NEW DRUG APPLICATION FOR KN026 AND HB1801 FOR ADVANCED BREAST CANCERFurther company coverage:1093.HK","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260818:nFWN44F0K4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1951186391.HKD","SG9999004220.SGD","LU1993786604.SGD","LU1960683339.HKD","LU0880133367.SGD","01093","IE00B543WZ88.USD","IE0008369823.USD","IE00BZ08YT58.USD","LU0067412154.USD","LU1813983027.USD","LU1226287529.USD","KURE","LU0315179316.USD","BK1521","LU1328277881.USD","LU0140636845.USD","LU1226287792.SGD","LU1226287875.USD","LU0501845795.SGD","LU1152091168.USD","IE00BZ08YS42.EUR","BK1515","LU2039709279.SGD","LU1807302812.USD","LU1008478684.HKD","IE0008368742.USD","BK1191","LU0072913022.USD","IE00BZ08YR35.GBP","LU0326950275.SGD","LU1226288170.HKD","IE00B5MMRT66.SGD","LU1152091754.HKD","IE00B031HY20.USD","LU1226288253.USD","HK0000165453.HKD","LU0314109678.HKD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":2,"totalSize":200,"code":"91000000","status":"200"}]}}